A
ARS Pharmaceuticals, Inc. (SPRY)
NGM – Real vaqt narxi. Valyuta: USD
8.07
-0.49 (-5.72%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.04
-0.03 (-0.37%)
Bozordan keyin: Mar 27, 2026, 7:28 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NGM – Real vaqt narxi. Valyuta: USD
8.07
-0.49 (-5.72%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
8.04
-0.03 (-0.37%)
Bozordan keyin: Mar 27, 2026, 7:28 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 7.28 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 7.06 | 5.63 | 10 | |
| Qarz/Kapital nisbati | 0.85 | 0.30 | 6.0 | |
| Qarz/Aktivlar nisbati | 0.30 | 1.04 | 7.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 6.8 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 1M | 30K | 89M | 84M | 84M |
| Yalpi foyda | 997K | -43K | 88M | 64M | 64M |
| Operatsion daromad | -36M | -68M | -3M | -179M | -179M |
| Sof foyda | -35M | -54M | 8M | -171M | -171M |
| EBITDA | -35M | -67M | -3M | -178M | -178M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 198.02 | -38.8 | 5.5 |
| Keyingi chorak | 156.58 | 17.22 | 9.5 |
| Joriy yil | 94.23 | 15.72 | 9.5 |
| Keyingi yil | 77.8 | 59.57 | 10 |
| O‘rtacha ball | 8.6 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -13.57 | 19.21 | 21.15 | 7.96 | 6.5 |
| Yil/Yil | -67.55 | -182.75 | -185.41 | -204.27 | 1.0 |
| 3 yil o‘rtacha | 98986.72 | -727.92 | -708.81 | -448.05 | 3.3 |
| 5 yil o‘rtacha | 59576.62 | -443.3 | -396.6 | -285.53 | 3.3 |
| O‘rtacha ball | 3.5 | ||||
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Umumiy qarz $97.0M naqd pul zahiralaridan ($41.3M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $284.9M jami joriy majburiyatlardan $39.1M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.8) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$43.5M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi